Doctor profile · Federal record

Dr. Ketan Shah, MD

Hematology & Oncology Physician (CMS: Hematology/Oncology) · Hematology & Oncology Physician · Medical Oncology Physician · Dayton, OH

  • NPI 1083664023
  • Accepts Medicare
  • MIPS 87.7 / 100 · 2023
  • 35 yrs in practice
  • Male
  • Group practice
  • No sanctions

Practice & contact

Operates at 2 locations .

NPPES Updated May 11, 2026
Primary practice
3120 Governors Place Blvd
Dayton, OH 454091328
(937) 293-1622
fax (937) 245-6308
Additional location
2300 Miami Valley Dr Ste 150
Centerville, OH 454591294
Mailing address
6680 Poe Ave Ste 200
Dayton, OH 454142855

Credentials & registration

NPPES · NUCC
NPI registered
May 2006 — 20 yrs on file
Profile last updated
January 7, 2022
Year of graduation
1991 — 35 yrs since
Specialty taxonomy
207RH0003X — NUCC code
State licenses (3)
Ohio #35061874 · Ohio #35061874-S · Ohio #35.061874
Medicaid
OH #0824666

Federal sanctions & exclusions

OIG LEIE Updated May 11, 2026

No sanctions, exclusions or revocations on file

Checked against OIG LEIE on NPI 1083664023. Last verified May 11, 2026.

Medicare procedures · 2023

Top services delivered

CMS Provider Utilization
Total services
28,258
Distinct HCPCS
10
Medicare allowed
$664,073
HCPCS Description Services Patients Avg allowed
J1453 Injection, fosaprepitant, 1 mg 9,150 27 $0
J9271 Injection, pembrolizumab, 1 mg 6,600 12 $54
J1756 Injection, iron sucrose, 1 mg 3,200 11 $0
J0897 Injection, denosumab, 1 mg 3,060 22 $23
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml 2,400 20 $0
J1100 Injection, dexamethasone sodium phosphate, 1 mg 1,250 37 $0
J2469 Injection, palonosetron hcl, 25 mcg 850 34 $1
99214 Established patient office or other outpatient visit, 30-39 minutes 315 158 $121
96413 Administration of chemotherapy into vein, 1 hour or less 204 65 $120
96375 Injection of additional new drug or substance into vein 166 55 $14

In context: peer comparison

Among 6 peers in Dayton Hematology & Oncology Physician, average services per provider: 1,183. This provider delivers 24× the peer median.

Open Payments

Industry payments received

CMS Open Payments
All-time total
$1,685
Transactions
59
Manufacturers
15
Payer (manufacturer) Industry Txns Amount
Janssen Biotech, INC. 6 $215.81
Merck Sharp & Dohme LLC 9 $215.32
Abbvie INC. 8 $167.46
Novartis Pharmaceuticals Corporation 10 $151.62
Incyte Corporation 3 $67.92
Celgene Corporation 3 $56.77
Gilead Sciences, INC. 2 $52.81
Array Biopharma INC 2 $52.38
AstraZeneca Pharmaceuticals Lp 3 $51.22
Bayer Healthcare Pharmaceuticals INC. 3 $51.18
Lilly USA, LLC 2 $48.58
Daiichi Sankyo INC. 3 $47.13
Genmab U.S., INC. 2 $45.83
Rigel Pharmaceuticals, INC. 1 $45.33
Pharmacosmos Therapeutics INC. 2 $43.38

By nature of payment

Food and Beverage
$1,659
Education
$26

Medicare Part D · 2023

Top prescriptions

CMS Part D Prescriber
Total claims
367
Patients
27
Total drug cost
$1,645,826
Drug Type Claims Patients Total cost
Hydroxyurea Generic 58 16 $2,016
Tamoxifen Citrate Generic 56 0 $3,210
Eliquis (Apixaban) Brand 34 0 $21,498
Calquence (Acalabrutinib Maleate) Brand 28 0 $439,921
Prednisone Generic 27 0 $246
Anastrozole Generic 25 0 $1,100
Imbruvica (Ibrutinib) Brand 22 0 $373,214
Warfarin Sodium Generic 20 0 $150
Jakafi (Ruxolitinib Phosphate) Brand 19 0 $363,133
Brukinsa (Zanubrutinib) Brand 18 0 $269,040

Hospital affiliations

CMS Hospital Compare

Frequently asked questions

Auto-generated from federal data
What is Dr. Ketan Shah's medical specialty?
Dr. Ketan Shah practices Hematology & Oncology Physician in Dayton, OH.
Where does Dr. Ketan Shah practice?
Dr. Ketan Shah practices at 3120 Governors Place Blvd, Dayton, OH 454091328. Office phone: 9372931622.
What is Dr. Ketan Shah's NPI?
Dr. Ketan Shah's National Provider Identifier (NPI) is 1083664023, issued by NPPES.
Does Dr. Ketan Shah accept Medicare assignment?
Yes. Dr. Ketan Shah accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Ketan Shah commonly perform?
Top Medicare-reported procedures in 2023: Injection, fosaprepitant, 1 mg (HCPCS J1453); Injection, pembrolizumab, 1 mg (HCPCS J9271); Injection, iron sucrose, 1 mg (HCPCS J1756). Source: CMS Medicare Physician & Other Practitioners file.